DENGUE-2 VACCINE - VIROLOGICAL, IMMUNOLOGICAL, AND CLINICAL-RESPONSES OF 6 YELLOW-FEVER IMMUNE RECIPIENTS

被引：53
|
作者：
BANCROFT, WH [1 ]
TOP, FH [1 ]
ECKELS, KH [1 ]
ANDERSON, JH [1 ]
MCCOWN, JM [1 ]
RUSSELL, PK [1 ]
机构：
[1] USA, MED RES INST INFECT DIS, DIV MED, FREDERICK, MD 21701 USA
来源：
INFECTION AND IMMUNITY | 1981年 / 31卷 / 02期
关键词：
D O I：
10.1128/IAI.31.2.698-703.1981
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：698 / 703
页数：6
相关论文
共 14 条
  • [1] DENGUE-2 VACCINE - DOSE-RESPONSE IN VOLUNTEERS IN RELATION TO YELLOW-FEVER IMMUNE STATUS
    SCOTT, RM
    ECKELS, KH
    BANCROFT, WH
    SUMMERS, PL
    MCCOWN, JM
    ANDERSON, JH
    RUSSELL, PK
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1983, 148 (06): : 1055 - 1060
  • [2] EXPRESSION OF THE STRUCTURAL PROTEINS OF DENGUE-2 VIRUS AND YELLOW-FEVER VIRUS BY RECOMBINANT VACCINIA VIRUSES
    HAHN, YS
    LENCHES, EM
    GALLER, R
    RICE, CM
    DALRYMPLE, J
    STRAUSS, JH
    [J]. ARCHIVES OF VIROLOGY, 1990, 115 (3-4) : 251 - 265
  • [3] DENGUE-2 VACCINE - VIREMIA AND IMMUNE-RESPONSES IN RHESUS-MONKEYS
    SCOTT, RM
    NISALAK, A
    ECKELS, KH
    TINGPALAPONG, M
    HARRISON, VR
    GOULD, DJ
    CHAPPLE, FE
    RUSSELL, PK
    [J]. INFECTION AND IMMUNITY, 1980, 27 (01) : 181 - 186
  • [4] Innate immune responses in human dendritic cells upon infection by chimeric yellow-fever dengue vaccine serotypes 1-4
    Deauvieau, Florence
    Sanchez, Violette
    Balas, Claire
    Kennel, Audrey
    De Montfort, Aymeric
    Lang, Jean
    Guy, Bruno
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 76 (01): : 144 - 154
  • [5] LETHAL 17D YELLOW-FEVER ENCEPHALITIS IN MICE .1. PASSIVE PROTECTION BY MONOCLONAL-ANTIBODIES TO THE ENVELOPE PROTEINS OF 17D YELLOW-FEVER AND DENGUE-2 VIRUSES
    BRANDRISS, MW
    SCHLESINGER, JJ
    WALSH, EE
    BRISELLI, M
    [J]. JOURNAL OF GENERAL VIROLOGY, 1986, 67 : 229 - 234
  • [6] Dengue-2 virus almost abolish yellow fever virus replication in C6/36 cells
    Costa, Emiliana P.
    Fonseca, Benedito A.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 75 (05): : 135 - 136
  • [7] YELLOW-FEVER, DENGUE-2 AND OTHER MOSQUITO-BORNE ARBOVIRUSES, IN BURKINA-FASO, FROM 1983 TO 1986 - ENTOMOLOGICAL AND EPIDEMIOLOGIC ASPECTS
    ROBERT, V
    LHUILLIER, M
    MEUNIER, D
    SARTHOU, JL
    MONTENY, N
    DIGOUTTE, JP
    CORNET, M
    GERMAIN, M
    CORDELLIER, R
    [J]. BULLETIN DE LA SOCIETE DE PATHOLOGIE EXOTIQUE, 1993, 86 (02): : 90 - 100
  • [8] Infection of Mosquito Cells (C6/36) by Dengue-2 Virus Interferes with Subsequent Infection by Yellow Fever Virus
    Abrao, Emiliana Pereira
    Lopes da Fonseca, Benedito Antonio
    [J]. VECTOR-BORNE AND ZOONOTIC DISEASES, 2016, 16 (02) : 124 - 130
  • [9] PATHOGEN DERIVED RESISTANCE IN MOSQUITO CELLS BY EXPRESSION OF THE PRM CODING REGION OF DENGUE-2 AND YELLOW-FEVER 17D VIRUS IN SENSE AND ANTISENSE ORIENTATIONS
    HIGGS, S
    OLSON, KE
    GAINES, P
    POWERS, A
    BLAIR, C
    CARLSON, J
    BEATY, BJ
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 223 - 223
  • [10] Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax™-DEN2) vaccine:: Phase I clinical trial for safety and immunogenicity
    Guirakhoo, Farshad
    Kitchener, Scott
    Morrison, Dennis
    Forrat, Remi
    McCarthy, Karen
    Nichols, Richard
    Yoksan, Sutee
    Duan, Xiaochu
    Ermak, Thomas H.
    Kanesa-Thasan, Niranjian
    Bedford, Philip
    Lang, Jean
    Quentin-Millet, Marie-Jose
    Monath, Thomas P.
    [J]. HUMAN VACCINES, 2006, 2 (02): : 60 - 67
12